Justin Sweeley is the Novasep's Senior Technology Manager for Biologics in North America. He has a Bachelor degrees in Molecular Biology, Chemistry, and Biochemistry from the University of Colorado at Boulder and also completed a PhD in Chemical and Biological Engineering from Colorado State University. Justin joined Novasep in 2018. He has 9 years of experience with process development in the pharmaceutical industry and prior to joining Novasep was as a senior scientist working on cGMP technology transfer for ADC projects Justin has a wide experience in Antibody Drug Conjugate process and analytical development, and a specific expertise in DoE based process development, and QbD based process validation.
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policy makers.